{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:55:37Z","timestamp":1772463337379,"version":"3.50.1"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T00:00:00Z","timestamp":1372291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0066847","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T22:15:56Z","timestamp":1372371356000},"page":"e66847","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Inflammation\u2019s Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Na\u00efve Patients with Bipolar II Disorder"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01188148","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sheng-Yu","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiou-Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po See","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian-Sheng","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Jen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Hui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzung Lieh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jau-Shyong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,6,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Akiskal HS, Pinto O (1999) The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am 22: 517\u2013534, vii.","DOI":"10.1016\/S0193-953X(05)70093-9"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00406-003-0437-2","article-title":"Recurrence of bipolar disorders and major depression. A life-long perspective","volume":"253","author":"J Angst","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0327(99)00038-5","article-title":"Bipolar II depression in late life: prevalence and clinical features in 525 depressed outpatients","volume":"66","author":"F Benazzi","year":"2001","journal-title":"J Affect Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0327(02)00327-0","article-title":"Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania","volume":"73","author":"F Benazzi","year":"2003","journal-title":"J Affect Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1192\/bjp.bp.106.030957","article-title":"The bipolar spectrum","volume":"190","author":"J Angst","year":"2007","journal-title":"Br J Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-5618.2007.00561.x","article-title":"Bipolar II disorder: arguments for and against a distinct diagnostic entity","volume":"10","author":"E Vieta","year":"2008","journal-title":"Bipolar Disord"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-0327(02)00324-5","article-title":"The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?","volume":"73","author":"LL Judd","year":"2003","journal-title":"J Affect Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1176\/ajp.156.7.1094","article-title":"Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder","volume":"156","author":"S Pallanti","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0010-440X(97)90088-2","article-title":"Differential features between bipolar I and bipolar II disorder","volume":"38","author":"E Vieta","year":"1997","journal-title":"Comprehensive Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Rihmer Z, Pestality P (1999) Bipolar II disorder and suicidal behavior. Psychiatr Clin North Am 22: 667\u2013673, ix\u2013x.","DOI":"10.1016\/S0193-953X(05)70101-5"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0010-440X(00)90043-9","article-title":"Insight and outcome in bipolar, unipolar, and anxiety disorders","volume":"41","author":"SN Ghaemi","year":"2000","journal-title":"Compr Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1176\/appi.ps.52.3.358","article-title":"Bipolar II disorder: symptoms, course, and response to treatment","volume":"52","author":"GM MacQueen","year":"2001","journal-title":"Psychiatr Serv"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4088\/JCP.08r04505","article-title":"Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature","volume":"70","author":"BI Goldstein","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"F Dickerson","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"YK Kim","year":"2007","journal-title":"J Affect Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1399-5618.2007.00444.x","article-title":"An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment","volume":"9","author":"EM Knijff","year":"2007","journal-title":"Bipolar Disord"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","article-title":"Cytokine profiles in bipolar affective disorder: focus on acutely ill patients","volume":"90","author":"SM O'Brien","year":"2006","journal-title":"J Affect Disord"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1503\/jpn.100080","article-title":"Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder","volume":"36","author":"J Soderlund","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","author":"F Boufidou","year":"2004","journal-title":"J Affect Disord"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopsych.2005.06.041","article-title":"Monocyte-derived dendritic cells in bipolar disorder","volume":"59","author":"EM Knijff","year":"2006","journal-title":"Biol Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.pnpbp.2008.01.006","article-title":"TNF-alpha as a molecular target in bipolar disorder","volume":"32","author":"E Brietzke","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hup.912","article-title":"Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study","volume":"23","author":"FG Nery","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An open-label, flexible-dose study of memantine in major depressive disorder","volume":"30","author":"JM Ferguson","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"CA Zarate Jr","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"CA Zarate Jr","year":"2006","journal-title":"Am J Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians","volume":"7","author":"A Fagiolini","year":"2005","journal-title":"Bipolar Disord"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group","volume":"57","author":"CL Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/092986707782360088","article-title":"Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review","volume":"14","author":"MF Reynolds","year":"2007","journal-title":"Curr Med Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"JL Elmslie","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2009.12.011","article-title":"The role of valproate in metabolic disturbances in bipolar disorder patients","volume":"124","author":"HH Chang","year":"2010","journal-title":"J Affect Disord"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10673220902899722","article-title":"Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment","volume":"17","author":"HA Kenna","year":"2009","journal-title":"Harv Rev Psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4088\/JCP.10m06068yel","article-title":"Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?","volume":"72","author":"NE Steen","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v67n0704","article-title":"Associations between bipolar disorder and metabolic syndrome: A review","volume":"67","author":"V Taylor","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"ref34","first-page":"613","article-title":"[Depressive symptoms, cortisol, visceral fat and metabolic syndrome]","volume":"53","author":"N Vogelzangs","year":"2011","journal-title":"Tijdschr Psychiatr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1111\/j.1742-4658.2009.07304.x","article-title":"Mechanisms of obesity and related pathology: linking immune responses to metabolic stress","volume":"276","author":"KP Karalis","year":"2009","journal-title":"FEBS J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/oby.2003.74","article-title":"Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression","volume":"11","author":"M Bullo","year":"2003","journal-title":"Obes Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0899-9007(01)00672-4","article-title":"Is obesity an inflammatory condition?","volume":"17","author":"UN Das","year":"2001","journal-title":"Nutrition"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/sj.mp.4001873","article-title":"Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions","volume":"11","author":"SR Bornstein","year":"2006","journal-title":"Mol Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2008.10.017","article-title":"Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice","volume":"204","author":"X Zhou","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the schedule for affective disorders and schizophrenia","volume":"35","author":"J Endicott","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.ALC.0000117832.62901.61","article-title":"Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence","volume":"28","author":"SY Huang","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"ref42","unstructured":"American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorder-IV-TR. Washington: American Psychiatric Association."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.134.11.1227","article-title":"Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group","volume":"134","author":"HS Akiskal","year":"1977","journal-title":"Am J Psychiatry"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archpsyc.1979.01780060025002","article-title":"Differentiation of primary affective illness from situational, symptomatic, and secondary depressions","volume":"36","author":"HS Akiskal","year":"1979","journal-title":"Arch Gen Psychiatry"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-0327(98)00142-6","article-title":"The emerging epidemiology of hypomania and bipolar II disorder","volume":"50","author":"J Angst","year":"1998","journal-title":"J Affect Disord"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s004060170065","article-title":"Is 4 days the minimum duration of hypomania in bipolar II disorder?","volume":"25","author":"F Benazzi","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"RC Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"M Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"M Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"SL Zeger","year":"1988","journal-title":"Biometrics"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1541-0420.2012.01758.x","article-title":"Model selection for generalized estimating equations accommodating dropout missingness","volume":"68","author":"CW Shen","year":"2012","journal-title":"Biometrics"},{"key":"ref52","unstructured":"Buchner A, Faul F, Erdfelder E (1996) G-power: A Priori, Post Hoc, and Compromise Power Analyses for the Macintosh. Version 2.1.1. ed. Germany.: University of Trier, Trier."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"F Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"M Visser","year":"1999","journal-title":"JAMA"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1520-037X.2002.1032.x","article-title":"C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease","volume":"5","author":"EA Bermudez","year":"2002","journal-title":"Prev Cardiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ejcn.2011.170","article-title":"The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used","volume":"66","author":"P Marques-Vidal","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1999.tb07783.x","article-title":"Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players","volume":"892","author":"P Zimmet","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"ref58","first-page":"275","article-title":"C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia","volume":"22","author":"B Vuksan-Cusa","year":"2010","journal-title":"Psychiatr Danub"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3132\/dvdr.2007.060","article-title":"Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with the relative change in body mass index between childhood and adulthood","volume":"4","author":"J Saltevo","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"25F","DOI":"10.1016\/S0002-9149(99)00211-8","article-title":"Hypertriglyceridemia, insulin resistance, and the metabolic syndrome","volume":"83","author":"SM Grundy","year":"1999","journal-title":"Am J Cardiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00125-004-1472-x","article-title":"C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men","volume":"47","author":"DE Laaksonen","year":"2004","journal-title":"Diabetologia"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Verma S, Yeh ET (2003) C-reactive protein and atherothrombosis\u2013beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 285: R1253\u20131256; discussion R1257\u20131258.","DOI":"10.1152\/ajpregu.00484.2003"},{"key":"ref63","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo","volume":"82","author":"V Mohamed-Ali","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1159\/000343302","article-title":"C-Reactive Protein Increases BBB Permeability: Implications for Obesity and Neuroinflammation","volume":"30","author":"H Hsuchou","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","article-title":"The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters","volume":"31","author":"CB Zhu","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/diabetes.49.8.1374","article-title":"Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity","volume":"49","author":"MC Alessi","year":"2000","journal-title":"Diabetes"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0895-7061(02)02978-3","article-title":"Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin","volume":"15","author":"E Porreca","year":"2002","journal-title":"Am J Hypertens"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nm0195-74","article-title":"The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis","volume":"1","author":"DJ Grainger","year":"1995","journal-title":"Nat Med"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI115393","article-title":"Production of transforming growth factor beta 1 during repair of arterial injury","volume":"88","author":"MW Majesky","year":"1991","journal-title":"J Clin Invest"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","article-title":"The transforming growth factor-beta family","volume":"6","author":"J Massague","year":"1990","journal-title":"Annu Rev Cell Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0008-6363(97)00033-3","article-title":"Circulating transforming growth factor beta 1 and coronary artery disease","volume":"34","author":"XL Wang","year":"1997","journal-title":"Cardiovasc Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.metabol.2004.02.007","article-title":"Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents","volume":"53","author":"YS Moon","year":"2004","journal-title":"Metabolism"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"E Brietzke","year":"2009","journal-title":"J Affect Disord"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0169-409X(98)00086-6","article-title":"Penetration of neurotrophins and cytokines across the blood-brain\/blood-spinal cord barrier","volume":"36","author":"W Pan","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.2008.08050746","article-title":"Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD","volume":"166","author":"JF Goldberg","year":"2009","journal-title":"Am J Psychiatry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0066847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T18:17:12Z","timestamp":1688321832000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0066847"}},"subtitle":[],"editor":[{"given":"Marianna","family":"Mazza","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,27]]},"references-count":75,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0066847","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,27]]}}}